DocMorris AG

Significant earnings improvement in 2023; e-prescription is standard in Germany - Seite 3

CO2 emissions cut by 13 per cent
DocMorris made further substantial progress as reflected in its third Sustainability Report 2023. The company achieved its targets in its four strategic pillars – Healthier People, Sustainable Planet, Caring Company and Reliable Partnerships – and set ambitious new targets for 2024. In 2023 DocMorris cut CO2 emissions by 13 per cent, reduced its already low gender pay gap, raised awareness of cybersecurity among employees and implemented a Supplier Code of Conduct.

Outlook
The ramp-up of the prescription medication business in Germany is not yet fully predictable. By way of indication, for the 2024 financial year DocMorris is expecting:

• an increase of more than 10 per cent in external revenue (including e-prescriptions);
• an improvement in adjusted EBITDA to between CHF 0 million and minus CHF 35 million (including e-prescriptions);
• capital expenditure of CHF 30 million to CHF 40 million.

In the medium term, an adjusted EBITDA margin of 8 per cent remains the target.

The Annual Report and Sustainability Report can be viewed online here and downloaded as a PDF in the download center.

Key financials, in million CHF	2023	2022 restated 1)
External revenue  2) 3)	1,037.5	1,159.5
Year-on-year-change of external revenue in % in local currency 2) 3)	-7.4%	-11.8% 4)
Year-on-year change of external revenue in % 2) 3)	-10.5%	-18.0% 4)
Net revenue 3)	966.9	931.0
Year-on-year change of net revenue in % 3)	3.9%	-15.8% 4)
Net revenue	969.5	931.0
Year-on-year change of net revenue in %	4.1%	-15.8% 4)
Gross margin in % of net revenue	21.0%	17.2%